VF
VRCA icon

Virtu Financial’s Verrica Pharmaceuticals VRCA Stock Holding History

Virtu Financial’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,305
Closed -$9K – 2089
2024
Q4 		$9K Buy
+1,305
New +$14.3K ﹤0.01% 1396
2022
Q4 		– Sell
-1,083
Closed -$32K – 2179
2022
Q3 		$32K Sell
1,083
-1,386
-56% -$47.5K ﹤0.01% 1302
2022
Q2 		$47K Buy
+2,469
New +$124K ﹤0.01% 1139
2021
Q2 		– Sell
-1,020
Closed -$155K – 2117
2021
Q1 		$155K Buy
+1,020
New +$141K 0.01% 1181

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return

Virtu Financial's VRCA Position: Q1 2025 in Review

Virtu Financial sold out of Verrica Pharmaceuticals (VRCA) in Q1 2025, closing a stake of 1,305 shares — an estimated $9K sold.

Virtu Financial first reported a position in VRCA in Q1 2021 and held it in 4 quarters. The position peaked at $155K in Q1 2021. 74 funds tracked by Wall St. Rank hold VRCA as of Q1 2025.

  • Virtu Financial reported no remaining Verrica Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 1,305 Verrica Pharmaceuticals shares in Q1 2025, an estimated $9K.
  • Virtu Financial first reported a position in Verrica Pharmaceuticals in Q1 2021 and held it in 4 quarters.
  • Virtu Financial's Verrica Pharmaceuticals position peaked at $155K in Q1 2021.
  • 74 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.